CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 62.11 CNY -8.12% Market Closed
Market Cap: 7.1B CNY
Have any thoughts about
CanSino Biologics Inc?
Write Note

Relative Value

The Relative Value of one CanSino Biologics Inc stock under the Base Case scenario is 77.71 CNY. Compared to the current market price of 62.11 CNY, CanSino Biologics Inc is Undervalued by 20%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
77.71 CNY
Undervaluation 20%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
64
vs Industry
14
Median 3Y
12.2
Median 5Y
14.8
Industry
2.5
Forward
8.4
vs History
vs Industry
Median 3Y
-4.4
Median 5Y
-5.4
Industry
21.9
Forward
-38.3
vs History
vs Industry
Median 3Y
-7.5
Median 5Y
-8
Industry
16.5
vs History
vs Industry
Median 3Y
-5.6
Median 5Y
-5.8
Industry
23.6
vs History
75
vs Industry
64
Median 3Y
1.8
Median 5Y
2.3
Industry
2.1
vs History
67
vs Industry
21
Median 3Y
8.4
Median 5Y
10.9
Industry
2.6
Forward
6.2
vs History
54
vs Industry
10
Median 3Y
8.9
Median 5Y
13.6
Industry
5.2
vs History
vs Industry
Median 3Y
-2.8
Median 5Y
-3.2
Industry
13.3
Forward
2 144.4
vs History
vs Industry
Median 3Y
-2.8
Median 5Y
-3.2
Industry
16.6
Forward
-12.4
vs History
vs Industry
Median 3Y
-5.6
Median 5Y
-5.9
Industry
15.6
vs History
vs Industry
Median 3Y
-3.5
Median 5Y
-4.3
Industry
19.1
vs History
69
vs Industry
73
Median 3Y
1.6
Median 5Y
2.5
Industry
1.9

Multiples Across Competitors

Competitors Multiples
CanSino Biologics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
CanSino Biologics Inc
SSE:688185
7.1B CNY 9.5 -9.9 -7.9 -7.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
CN
CanSino Biologics Inc
SSE:688185
Average P/E: 32.4
Negative Multiple: -9.9
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top